Consistently, analysis of the same public data37 showed increased mRNA levels of PLCγ2 targets such as ITPR3 and PRKCβ in B-ALL compared to normal PBMCs (Supplementary Fig. 1h–j). This evidence concerns the gene PRKCB and precursor B-cell acute lymphoblastic leukemia.